Heslop HE - Search Results

1

Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy.

Krance RA, Kuehnle I, Rill DR, Mei Z, Pinetta C, Evans W, Brown MP, Pulé M, Heslop HE, Brenner MK. Krance RA, et al. Among authors: heslop he. Biol Blood Marrow Transplant. 2003 Apr;9(4):273-81. doi: 10.1053/bbmt.2003.50024. Biol Blood Marrow Transplant. 2003. PMID: 12720220 Free article. Clinical Trial.

2

Reconstitution of the T cell receptor alpha beta repertoire in recipients of allogeneic BMT.

Rencher SD, Hanif I, Heslop HE, Turner VE, Brenner MK, Hurwitz JL. Rencher SD, et al. Among authors: heslop he. Bone Marrow Transplant. 1992 Dec;10(6):521-7. Bone Marrow Transplant. 1992. PMID: 1490202

3

IL-2 infusion abrogates humoral immune responses in humans.

Gottlieb DJ, Prentice HG, Heslop HE, Bello C, Brenner MK. Gottlieb DJ, et al. Among authors: heslop he. Clin Exp Immunol. 1992 Mar;87(3):493-8. doi: 10.1111/j.1365-2249.1992.tb03025.x. Clin Exp Immunol. 1992. PMID: 1544235 Free PMC article.

4

Immunotherapy of leukemia.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Leukemia. 1992;6 Suppl 1:76-9. Leukemia. 1992. PMID: 1548941 Review.

5

Graft-versus-host reactions and bone-marrow transplantation.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Curr Opin Immunol. 1991 Oct;3(5):752-7. doi: 10.1016/0952-7915(91)90108-d. Curr Opin Immunol. 1991. PMID: 1836732

6

Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function.

Bello-Fernandez C, Bird C, Heslop HE, Gottlieb DJ, Reittie JE, Rill DM, Holland M, Prentice HG, Brenner MK. Bello-Fernandez C, et al. Among authors: heslop he. Blood. 1991 Mar 15;77(6):1283-9. Blood. 1991. PMID: 1900445 Free article.

7

Graft versus leukaemia effects after marrow transplantation in man.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Baillieres Clin Haematol. 1991 Jul;4(3):727-49. doi: 10.1016/s0950-3536(09)90010-5. Baillieres Clin Haematol. 1991. PMID: 1958889 Review.

8

Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regeneration.

Heslop HE, Duncombe AS, Reittie JE, Bello-Fernandez C, Gottlieb DJ, Prentice HG, Hoffbrand AV, Brenner MK. Heslop HE, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1704-5. Transplant Proc. 1991. PMID: 1989334 No abstract available.

9

Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus.

Duncombe AS, Meager A, Prentice HG, Grundy JE, Heslop HE, Hoffbrand AV, Brenner MK. Duncombe AS, et al. Among authors: heslop he. Blood. 1990 Sep 1;76(5):1046-53. Blood. 1990. PMID: 2168224 Free article.

10

Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy.

Reittie JE, Gottlieb D, Heslop HE, Leger O, Drexler HG, Hazlehurst G, Hoffbrand AV, Prentice HG, Brenner MK. Reittie JE, et al. Among authors: heslop he. Blood. 1989 Apr;73(5):1351-8. Blood. 1989. PMID: 2495037 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters